As informed in Stock Exchange Announcement No. 5/2007 the Board of Directors of Coloplast has decided to initiate a share buy-back programme in the order of DKK 1 billion during 2007 and part of 2008. A first buy-back programme within the scope of the authority will be exercised in the period from 5 March 2007 to 15 August 2007. The volume of trading in own shares will be limited to a maximum total market value of DKK 500 million. This programme is expected to be followed by an additional programme in August 2007. Under the programme the following transactions have been executed during the period 6.8.07 - 10.8.07 (see attached PDF).
Recommended Reading
-
The global leader within intimate healthcare today announced FDA approval of Titan Prime, an inflatable penile prosthesis (IPP) that represents the company’s next-generation device and will be...
Read More -
2025/26Interim financial results, H1 2025/261 October 2025 - 31 March 2026 Coloplast delivered Q2 organic growth of 6% and 6% EBIT growth1 in constant currencies. Strong quarter in Chronic Care and...
Read More